Dr. Evangelia K. Kirimis, MD

Dr. Kirimis practices at UCLA Medical Plaza in Pasadena, California.

Dr. Kirimis' NPI, 1073755278, was assigned on April 2, 2009. Dr. Kirimis graduated from Keck School of Medicine of USC in 2005. Dr. Kirimis holds California license A99632.

Dr. Kirimis' primary practice is UCLA Medical Plaza, at 55 E California Blvd, Pasadena, CA 91105 in Los Angeles County. The practice phone is (310) 794-1276.

Dr. Kirimis' primary practice is UCLA Medical Plaza in Pasadena, California. Dr. Kirimis is also affiliated with Huntington Hospital. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Kirimis to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kirimis practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kirimis' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kirimis is board certified in hematology by the American Board of Internal Medicine. Dr. Kirimis is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Kirimis treats.

CMS data shows 70,284 Medicare services from Dr. Kirimis across 26 procedure codes in 2024, for 540 Medicare patients. Medicare paid $449,037 for them.

CMS counts 540 Medicare patients who saw Dr. Kirimis in 2024. The largest group is 75 to 84, with 234 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kirimis' median patient age at 65, with 75% women.

In 2024, Dr. Kirimis wrote 719 Medicare Part D claims for 197 patients. 81% of them were for generic drugs. CMS names the drug for 579 of them, across 10 drugs with 11 or more claims each, at $657,524 in total drug cost. In 2023, CMS named 599 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kirimis for performance year 2024, reported as part of a group. Dr. Kirimis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kirimis as offering telehealth.

CMS Open Payments shows 3 general payments to Dr. Kirimis from 3 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 52% of the total. Bristol-Myers Squibb Company paid the most, $108.

Dr. Kirimis graduated from Keck School of Medicine of USC in 2005.

Dr. Kirimis is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.